The inhibitor of DNA-binding (ID) proteins are dominantnegative inhibitors of basic helix-loop-helix transcription factors that have multiple functions during development and cellular differentiation. High-level expression of some ID family members has been observed in human malignancies, and in some cases was correlated with poor clinical prognosis. Ectopic ID1 expression extends the life span of primary human epithelial cells, inhibits cellular differentiation and induces centrosome duplication errors, thus suggesting that ID1 may have oncogenic activities. ID1 can bind to the proteasomal subunit S5A/Rpn10, but the biological consequences of the interaction have not been studied in detail. Here, we show that ID1's ability to induce supernumerary centrosomes correlates with S5A binding. Similar to ID1, a fraction of the S5A protein localizes to centrosomal structures. Furthermore, partial depletion of S5A by RNA interference causes accumulation of cells with supernumerary centrosomes. These results are consistent with the model that ID1 dysregulates centrosome homeostasis at least in part by interfering with S5A activities at the centrosome.
Introduction
The inhibitor of DNA-binding (ID) proteins, ID1-4, are negative regulators of basic helix-loop-helix (bHLH) transcription factors that lack the DNA binding domain. ID proteins form DNA-binding incompetent heterodimers with bHLH transcription factors thereby inhibiting their transcriptional activities (Benezra et al., 1990) . Individual ID-proteins have been linked to inhibiting cellular differentiation, inhibition of bHLHand other transcription factors (Benezra et al., 1990; Jen et al., 1992; Kreider et al., 1992; Ohtani et al., 2001; Roberts et al., 2001) , modulating apoptosis (Florio et al., 1998; Ling et al., 2003) , cooperating with the retinoblastoma tumor suppressor pathway (Iavarone et al., 1994; Hara et al., 1996) , extending cellular life span (Alani et al., 1999; Nickoloff et al., 2000; Tang et al., 2002) , regulating angiogenesis (Lyden et al., 2001) as well as cardiac development (Fraidenraich et al., 2004) , and stem cell maintenance (Ying et al., 2003) . ID expression is induced as part of the immediate-early transcriptional response to growth factors and is regulated in a cell cycle-dependent manner. ID2 and ID3 are phosphorylated during G1-S-phase transition by cyclin-dependent kinase 2 (CDK2) Cyclin A or Cyclin E complexes (Deed et al., 1997; Hara et al., 1997) . This phosphorylation event may trigger their ubiquitin-mediated proteasomal degradation and/or alter their protein-binding specificities (Deed et al., 1997; Bounpheng et al., 1999) . All ID proteins but ID3 contain a destruction box (D box), a recognition sequence for the anaphase-promoting complex (APC/ C) (Lasorella et al., 2006) , targeting them for ubiquitinmediated proteasomal degradation. In addition, ID1 can interact with the 26S proteasome subunit S5A/ Rpn10 (Anand et al., 1997) . S5A does not possess proteolytic activity and may shuttle substrates to the 26S proteasome (reviewed in Goldberg, 2003) . Deletion of the Drosophila melanogaster S5A/Rpn10 gene causes mitotic defects with overcondensed chromosomes, premature sister chromatid separation, atypical mitotic figures with monopolar mitoses and an increase in aneuploid and polyploid cells (Szlanka et al., 2003) .
We have shown previously that a fraction of ID1 localizes to centrosomal structures, and that forced expression of ID1 can lead to rapid overduplication of centrosomes (Hasskarl et al., 2004) . Centrosomes consist of a pair of centrioles surrounded by pericentriolar material. They are the major microtubule organizing centers in mitotic and postmitotic cells and coordinate critical cellular activities. In normal cells, the centrosome duplicates in synchrony with the cell cycle to generate a bipolar mitotic spindle to ensure equal chromosome segregation during mitosis (reviewed in Meraldi and Nigg, 2002) . Most cancer cells exhibit numerical and/or structural centrosome abnormalities (Doxsey, 2001) . Numerical centrosome abnormalities can arise by three major mechanisms, cytokinesis failure, cell fusion and aberrant centriole synthesis. Cytokinesis failure or cell fusion gives rise to tetraploid cells that contain two centrosomes in G1. When such abnormal cells reenter the cell cycle, each centrosome is normally duplicated during S-phase resulting in a tetrapolar mitosis that may give rise to aneuploid progeny (reviewed in Storchova and Pellman, 2004) . Certain oncogenic insults result in uncoupling of centrosome duplication from DNA replication and abnormal centrosome numbers arise in diploid cells (Duensing et al., 2001) . Here, we demonstrate that the ID1-interacting protein S5A may modulate this ID1 activity, and that the ability of ID1 to associate with S5A correlates with its capacity to induce supernumerary centrosomes. Similar to ID1, a fraction of S5A protein is localized at centrosomes. Furthermore, S5A depletion by RNA interference leads to accumulation of cells with supernumerary centrosomes similar to what we observed with ID1-expressing cells, implying a role of S5A during centrosome duplication and/or maturation.
Results
Ectopic expression of wild-type ID1 and various ID1-mutants that can bind to proteasome subunit S5A/Rpn10 can induce centrosome abnormalities Ectopic expression of ID1 can lead to accumulation of cells with supernumerary centrosomes. A functional N terminus and HLH-region are important for this activity. One difference between ID1 and the other IDs is that the latter contain a CDK2-consensus phosphorylation site (SPVR). To rule out that this was the reason for the different effect of ID1 on centrosome duplication, the SPVR sequence was introduced in ID1, yielding ID1-CDK2. Expression of ID1-CDK2 resulted in an increase of cells with supernumerary centrioles (n>4) in USOS cells (2.570.3-fold; Po0.001) and primary human keratinocytes (HFK) (4.170.1-fold; Po0.001) similar to wild-type ID1. As expected, expression of an ID1-mutant in which the HLH-region was deleted did not cause supernumerary centrosomes (Figure 1a) .
Since deletion of the ID1-interactor S5A in Drosophila results in mitotic defects (Szlanka et al., 2003) , we examined the relation of ID1 and S5A in more detail, and performed co-immunoprecipitation experiments. Coexpression of hemagglutinin (HA)-tagged full-length S5A and FLAG-tagged wild-type (wt) ID1 and ID1-mutants in U2OS confirmed the interaction of wt-ID1 with S5A (Figures 1b and 3c) . Furthermore, we detected efficient co-precipitation of S5A by the ID1-CDK2 and ID1-DCOOH mutants, whereas the ID1-V98G, the ID1-DHLH or the ID1-DNH2 mutants only weakly coprecipitated S5A (Figure 1a ).
Ectopic S5A expression inhibits ID1-mediated induction of supernumerary centrosomes To determine the effects of S5A on ID1-induced centrosome abnormalities, we performed transient transfection experiments in U2OS cells stably expressing centrin-GFP (U2OS-C). Expression of ID1 resulted in a 2.7 (70.2)-fold increase of cells with abnormal centriole numbers, whereas ectopic S5A expression did not significantly alter centriole numbers (Figure 2a ). Cotransfection of S5A, however, abrogated the ability of ID1 to induce supernumerary centrosomes. Co-transfection of a S5A-mutant with a deletion of the C terminal ubiquitin interacting motives (UIM) sequences was fully competent in inhibiting ID1-induced centrosomal alterations ( Figure 2a ). Consistent with a previously published report (Anand et al., 1997 ) ID1 levels were not affected by S5A co-transfection (Supplementary Figure 1a) , and similarly, ID1 or S5A levels were unchanged in cells with stable S5A or ID1 expression, respectively (Supplementary Figure 1b) . As expected (Anand et al., 1997) , the ubiquitination status and halflife of endogenous ID1 was not significantly altered in cells with S5A-overexpression (data not shown).
S5A expression does not affect induction of centrosome abnormalities by other oncogenes
Given that the proteasome has been implicated in regulating centrosome duplication, we considered the possibility that the observed ID1-inhibitory effect of S5A might not be specific. Hence, we analysed whether S5A specifically represses ID1-mediated centrosome abnormalities or whether it can also suppress centrosome alterations induced by other oncogenes. The human papillomavirus type 16 E7 oncoprotein (HPV16 E7) induces centrosome duplication errors in primary human diploid epithelial cells (Duensing et al., 2000) through a CDK2-dependent mechanism . Similarly, the c-Myc oncogene has been linked to induction of centrosome abnormalities (Duensing et al., 2003; Stavropoulou et al., 2005) . U2OS-C cells were transiently transfected with expression vectors encoding HA-tagged HPV16 E7 or c-Myc. Consistent with earlier reports, HPV16 E7 or c-Myc expression caused a 2.770.6 (Po0.001) and 2.470.2 fold (Po0.001) increase of cells with supernumerary centrosomes, respectively. Co-transfection of ID1 with HPV16 E7 caused a further increase of cells with supernumerary centrosomes (3.9870.1 fold, Po0.001). In contrast, co-expression of ID1 with c-Myc did not result in a comparable increase in the incidence of supernumerary centrosomes ( Figure 2b ). In contrast to what we observed with ID1, co-expression of S5A, did not affect the ability of HPV16 E7 or c-Myc to induce supernumerary centrosomes (Figure 2c) .
A fraction of S5A is localized at centrosomes Since S5A associates with ID1 and abrogates ID1-mediated centrosome abnormalities, we hypothesized that similar to ID1 a fraction of S5A might be located at centrosomes. Immunofluorescence experiments in various human cell lines revealed predominantly cytoplasmic S5A staining. While the staining pattern exhibited some variation depending on the cell type, the fixation method, and the antibody used, we consistently detected S5A staining on cytoplasmic dot-like structures, reminiscent of centrosomes. Centrosomal localization of S5A was substantiated by colocalization of the S5A-signal with the centrosome markers g-tubulin ( Figure 3a ) and pericentrin (Figure 3b ). Further analyses revealed centrosomal S5A staining throughout the cell division cycle (Figure 3 and Supplementary Figures 2 and 3 ), similar to that reported for ID1 (Hasskarl et al., 2004) . Due to technical limitations we were not able to perform triple staining for centrosomes, ID1 and S5A, but we detected co-localization of endogenous S5A and ID1 to cytoplasmic dots, which presumably represent centrosomes (Figure 3c ).
S5A depletion in U2OS cells results in accumulation of cells with supernumerary centrosomes
We next investigated whether S5A may regulate centrosome homeostasis. Two S5A specific and one nonspecific control oligonucleotides were cloned into the short hairpin (sh)RNA expression vector pSUPER.retro (Brummelkamp et al., 2002) and tested for S5A depletion. Immunoblot analyses revealed an approximately 40% decrease of S5A protein levels in U2OS cells at 36-48 h after transfection with each of the SA5-specific shRNAs, compared to cells expressing control shRNA (Figure 4a ). . Cells were lysed and immunoprecipitated using Flag antibody (M2). Protein complexes were eluted using a 3 Â Flag peptide and subjected to SDS-PAGE and immunoblotting with the indicated antibodies. ID1-wt: wildtype ID1; ID1-V98G: ID1 point mutation in the second helix domain at amino acid 98 resulting in a substitution of V to G that disrupts HLH dimerization, corresponding to the V91P mutant in murine Id1; ID1-DNH2: deletion of N terminal 64 amino acids; ID1-DCOOH: deletion of C terminal 44 amino acids; ID1-DHLH-FLAG: deletion of the HLH region (helix 1, loop and 50% of helix 2).
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In additional experiments, U2OS-C cells were cotransfected with the shRNA-vectors and an expression vector for DSRed to identify cotransfected cells. In these experiments S5A depletion caused a 2.670.6 and 3.471.1 fold (Po0.005) increase of cells with supernumerary centrioles (n>4), respectively (Figures 4b and c) .
Discussion
Members of the ID-family of transcriptional regulators control diverse cellular processes. Stability of all ID proteins appears to be regulated by the ubiquitin proteasome system (Anand et al., 1997; Bounpheng et al., 1999; Fajerman et al., 2004; Lasorella et al., 2006) . Indeed, ID proteins can bind different components of , 1997) , and ID1 and ID3 bind to the JAB1 protein, a subunit of the COP9 signalosome (Bounpheng et al., 1999; Berse et al., 2004; Trausch-Azar et al., 2004) . Binding of ID3 to the bHLH protein E47 stabilizes ID3 and partly protects it from proteasomal degradation (Bounpheng et al., 1999) . S5A harbors an N-terminal von Willebrand domain, and two C-terminal ubiquitin interacting motifs (UIM), which are important for S5A binding to multiubiquitinated proteins (Hofmann and Falquet, 2001) . S5A binds to ID1 via the von Willebrand domain in an ubiquitin-independent manner. Binding of S5A to ID1 can lead to dissociation of ID1 heterodimers and can restore DNA binding of bHLH transcription factors (Anand et al., 1997) . A direct role of ID proteins in tumor development has been suspected, especially for ID1, as it is frequently overexpressed in human malignancies, and in some cases high expression has been linked to unfavorable clinical outcome (reviewed in Perk et al., 2005) . ID1, but not ID2, ID3 or ID4, may contribute to oncogenesis by subverting centrosome duplication (Hasskarl et al., 2004) . Here, we show that the ability of ID1 to cause centrosome abnormalities correlates with its ability to associate with proteasome subunit S5A, and that ectopic expression of S5A can reverse ID1-mediated centrosomal abnormalities. Several findings support our hypothesis that ID1-induced centrosome amplification is mediated through its association with S5A. First, ID1 levels are not decreased upon ectopic S5A expression, and ID1 stability is not significantly altered upon S5A expression (Anand et al., 1997, Supplementary Figure 1 , and data not shown). Second, S5A does not specifically associate with ubiquitinated ID1, and non-ubiquinated ID1 binds to the von Willebrand domain of S5A outside of the ubiquitin interacting motif (Anand et al., 1997) . Thus, the observed repression of ID1-induced centrosomal abnormalities by S5A is not merely due to decreased ID1 levels. Furthermore, S5A does not inhibit induction of supernumerary centrosomes by the HPV16 ID1-S5A centrosomes J Hasskarl et al E7 or c-Myc oncogenes. Since a fraction of cellular ID1 protein is localized at centrosomal structures, ID1 may regulate centrosome homeostasis directly at centrosomes. Analysis of the subcellular localization of endogenous S5A protein revealed that, similar to ID1, a fraction of cellular S5A is localized at centrosomes. Similar centrosomal localization patterns have been reported for other components of the proteasome (Freed et al., 1999; Wigley et al., 1999; Fabunmi et al., 2000; Andersen et al., 2003) , Localization of proteasome components at the centrosome might be crucial for centrosome duplication (reviewed in Hinchcliffe and Sluder, 2001) . Supporting an important function of proteasome components during centrosome duplication are our findings that knockdown of S5A by shRNA caused an increase of cells with supernumerary centrioles (Figure 4) . Although partial depletion of S5A resulted in a similar induction of supernumerary centrosomes, we propose that ID1 may cause centrosome abnormalities by altering a critical, yet unknown, function of S5A at centrosomes rather than by downregulating S5A. Alternatively, ID1 may interfere with the activity of other binding partners of S5A such as CUL1 (Bloom et al., 2006) . Further studies will help to elucidate the complex regulatory network of the ID proteins and their contribution to carcinogenesis.
Materials and methods

Cell culture
Primary human foreskin keratinocytes (HFK) were prepared as described previously (Alani et al., 1999) and maintained in serum-free keratinocyte growth medium (KGM; GIBCO BRL, Gaithersburg, MD, USA) containing gentamycin (20 mg ml
À1
), amphotericin B (2.5 mg ml
), penicillin (50 U ml
) and streptomycin (50 mg ml
). HeLa, U2OS and HaCaT cells were maintained in Dulbecco's minimal eagel's media (DMEM) with 10% fetal bovine serum, Saos-2 cells in DMEM with 20% FBS, containing penicillin (50 U ml À1 ), streptomycin (50 mg ml À1 ) and glutamine (2 mM).
Transfections
Cells were transfected using Fugene6 according to the manufacturer's recommendations (Roche Molecular Biochemicals, Indianapolis, IN, USA). At 48 h after transfection, cells were processed for further experiments or selected with 1 mg ml À1 G418 or 10 mg ml À1 puromycin (Sigma, St Louis, MO, USA). For centrosome determinations after transient transfection, cells were cotransfected with a vector encoding DsRed (BD Clontech, Palo Alto, CA, USA) and only transfected, DsRedpositive cells were analysed. Experiments were done in triplicate and at least 3 Â 100 cells were counted per individual transfection. Transfection was monitored by immunoblot detection of the expressed proteins. For quantification of centriole abnormalities the number of mononuclear cells (that is, cells containing one nucleus) containing >4 centrioles was determined and normalized to control transfected cells.
Expression plasmids used were: centrin-GFP (D'Assoro et al., 2001) pCMVneo, pCDNA3 (Invitrogen, Carlsbad, CA, USA), p-HA, pHA-Dest (N-terminal HA-tag), pFLAG, pFLAG-Dest (N-terminal FLAG-tag), pID1-wt-FLAG, pID1-V98G-FLAG, pID1-DNH2-FLAG and pID1-DCOOH-FLAG (Hasskarl et al., 2004) . ID1 cDNA was digested with MaeII to remove the HLH-domain. The corresponding DNA fragments were religated to yield pID1-DHLH-FLAG. ID1 cDNA was used as template for generation of the ID1-CDK2 mutant. The Quickchange kit (Stratagene, La Jolla, CA, USA) was used to generate the CDK2 mutant using the following primers: ID1 CDK2f: ACCTGAAAGTCGCCAGTCCCGT GAGGGCCACCGCCGCCGCGGGC; ID1 CDK2r: GCCC GCGGCGGCGGTGGCCCTCACGGGACTGGCGACTTT CATGGT. PCR products were cloned into pENTR/ D-TOPO (Invitrogen, Carlsbad). pHA-Dest was generated by cloning the HA-tag into the EcoRI-HindIII-site of pCDNA3. The Gateway cassette was cloned into the EcoRV site. Human full-length S5A was PCR cloned from a cDNA (kindly provided by PM Howley, Pathology Department, Harvard Medical School, Boston, MA, USA) using the taqPCR Kit (Qiagen, Valencia, CA, USA).
pS5A-DCOOH was PCR-cloned from full-length S5A using AGCTTGCCACCATGTACCCATACGATGTTCCAGATT ACGCTCTTG as reverse primer. The pSUPER.retro plasmid was used to generate the RNAi retroviral vectors pSUPER-S5A-A (forward: GATCCCCCATAGTTTGTCATTCAAAG TTCAAGAGACTTTGAATGACAAACTATGTTTTTGGA AA; reverse: AGCTTTTCCAAAAACATAGTTTGTCATT CAAAGTCTCTTGAACTTTGAATGACAAACTATGGG), and pSUPER-S5A-B (forward: GATCCCCCAACGTGGGC CTTATCACATTCAAGAGATGTGATAAGGCCCACGTT GTTTTTGGAAA; reverse: AGCTTTTCCAAAAACAACG TGGGCCTTATCACATCTCTTGAATGTGATAAGGCCC ACGTTGGGG). As control, pSUPER-scr was generated using a random sequence (forward: GATCCCCAACGTGGGC CTTATCACATTCAAGAGATGTGATAAGGCCCACGTT TTTTTGGAAA; reverse: AGCTTTTCCAAAAAAACGTG GGCCTTATCACATCTCTTGAATGTGATAAGGCCCAC GTTGGG). All sequences were verified by DNA sequencing.
Immunofluorescence and immunoblotting
Cells were grown on coverslips, fixed and permeabilized in methanol and rehydrated with phosphate buffered saline (PBS). Before immunostaining, cells were blocked in normal goat serum (1:10 in PBS containing 5% bovine serum albumin). Nuclei were visualized with Hoechst 33258. Cells were analysed using a Zeiss Axioplan 2 epifluorescence microscope equipped with a Zeiss AxioCam digital camera, and a Leica TCS SP2 AOBS confocal microscope, software version 1.61, V. 2.51347A.
Cell lysates for Immunoblot experiments were prepared as described previously (Alani et al., 1999) , and western blotting was performed according to standard procedures. Antibodies used were ID1 (C20) (Santa Cruz Biotechnology, Santa Cruz, CA, USA), actin (Chemicon, Temecula, CA, USA), g-tubulin GTU-88, Flag M2 (Sigma, St Louis, MO, USA), HA (Roche, Indianapolis, IN, USA), anti-HA tag ab9110 (Abcam, Cambridge, UK), S5A FK2, polyubiquitin FK2 (Affiniti Research Products, Mamhead Castle, UK), S5A PA1-966 (Affinity Bioreagents, Golden, CO, USA) and pericentrin (PRB-432C, Covance, Berkeley, CA, USA). Secondary antibodies were goat anti-mouse Alexa Fluor 488, and Alexa Fluor 568 goat anti-rabbit (Molecular Probes, Eugene, OR, USA) for immunofluorescence experiments and HRP-conjugated donkey anti-rabbit and donkey anti-mouse (Santa Cruz Biotechnology) for immunoblotting.
Statistical methods
Student's t-test was used where applicable. Results of at least three independent experiments and at least 100 cells evaluated per experiment are depicted unless indicated otherwise.
